Cancer of the kidney

Clinical Obstetrics and Gynecology

Volumn 45, Issue 3, 2002, Pages 884-891

  Zweizig, Susan L ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTINEOPLASTIC AGENT; CYTOKINE; CYTOTOXIC AGENT; HORMONE; IMMUNOMODULATING AGENT; INTERFERON; INTERLEUKIN 2;

CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER GENETICS; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CANCER SCREENING; CANCER SURGERY; CARCINOGENESIS; COMPUTER ASSISTED TOMOGRAPHY; DRUG RESPONSE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HEART INFARCTION; HUMAN; KIDNEY CANCER; KIDNEY FAILURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGNOSIS; REVIEW;

CARCINOMA, RENAL CELL; FEMALE; HUMANS; KIDNEY NEOPLASMS; LYMPH NODE EXCISION; NEPHRECTOMY; PROGNOSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0036403791     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003081-200209000-00035     Document Type: Review

References (27)

1. Jemal A, Thomas A, Murray T, et al. Cancer statistics 2002. CA Cancer J Clin. 2002;52:25.
2. Homma Y, Kawabe K, Kitamura T, et al. Increased incidental detection and reduced mortality in renal cancer: Recent retrospective analysis at eight institutions. Int J Urol. 1995;2:77-80.
3. Pantuck A, Zisman A, Belldegrun A. The changing natural history of renal cell carcinoma. J Urol. 2001;166:1611-1623.
4. Chow W, Devesa SS, Waren JL, et al. Rising incidence of renal cell cancer in the United States. JAMA. 1999;281:1628-1631.
5. Jayson M, Sanders H. Increased incidence of seredipitously discovered renal cell carcinoma. Urology. 1998;51:203-205.
6. Luciani LG, Cestori R, Tallrigo C. Incidental renal cell carcinoma: Age and stage characterization and clinical implications: Study of 1092 patients (1982-1997). Urology. 2000;56:58-62.
7. Lindblad P, Mellemgaard A, Schlehofere B, et al. International renal cell cancer study. V. Reproductive factors, gynecologic operations and exogenous hormones. Int J Cancer. 1995;61:192-198.
8. Mellemgaard A, Lindblad P, Schlehofer B, et al. International Renal Cell Cancer Study. III. Role of weight, height, physical activity and use of amphetamines. Int J Cancer. 1995;60:350-354.
9. Mandel JS, McLaughlin JK, Schlehofer B, et al. International Renal Cell Cancer Study. IV. Occupation. Int J Cancer. 1995;61:601-605.
10. McLaughlin JK, Mandel JS, Blot WJ, et al. A population based case control study of renal cell carcinoma. J Natl Cancer Inst. 1984;72:275-278.
11. Linehan WM, Zbar B, Bates S, et al. Cancer of the kidney and ureter. In: DeVita VT, Ed. In Cancer: Principles and Practice of Oncology. Philadelphia: Lippincott Williams & Wilkins, 2001:1362-1364.
12. Motzer RJ, Bander NH, Nanus DM. Renal cell carcinoma. N Engl J Med. 1996;335:865-875.
13. Mihara S, Karoda K, Yoshiota R, et al. Early detection of renal cell carcinoma by ultrasonographic screening: Based on the results of 13 years screening in Japan. Ultrasound Med Biol. 1999;25:1033-1036.
14. Hellsten S, Johnsen J, Berge T, et al. Clinically unrecognized renal cell carcinoma: Diagnostic and pathologic aspects. Eur Urol. 1990;18(suppl 2):2-3.
15. Skinner DG, Calvin RB, Vermillion CD, et al. Diagnosis and management of renal cell carcinoma: A clinical and pathologic study of 309 cases. Cancer. 1971;28:1165-1177.
16. Maldazys JD, deKernion JB. Prognostic factors in metastatic renal carcinoma. J Urol. 1986;136:376-380.
17. Amendola MA, Bree RL, Pollack HM, et al. Small renal cell carcinomas: Resolving a diagnostic dilemma. Radiology. 1988;166:637-641.
18. Tsukamoto T, Kumamoto Y, Takahashi A, et al. Tumor size of renal carcinoma: Its clinical implication. Urol Int. 1994;378-383.
19. Tsui KH, Shuarts O, Smith RB, et al. Prognostic indicators for renal cell carcinoma: A multivariate analysis of 643 patients using the revised 1997 TNM staging criteria. J Urol. 2000;163:1278-1281.
20. McCaffrey JA, Molzer RJ. What is the role of nephrectomy in patients with metastatic renal cell carcinoma? Semin Oncol. 1996;23:xix-xx.
21. Lee C, Katz J, Shi W, et al. Surgical management of renal tumors 4 cm or less in a contemporary cohort. J Urol. 2000;163:730-734.
22. Novick AC, Streem S, Montie JE, et al. Conservative surgery for renal cell carcinoma: A single center experience with 100 patients. J Urol. 2002;167:878-883.
23. Lerner SE, Hawkins CA, Blute MC, et al. Disease outcome in patients with low-stage renal cell carcinoma treated with nephron sparing or radical surgery. J Urol. 1996;155:1868-1873.
24. Phillips PE, Messing EM. Role of lymphadenectomy in the treatment of renal cell carcinoma. Urology. 1993;41:9-15.
25. Flanigan RC, Salmon SE, Blumenstein BA, et al. Cytoreductive nephrectomy in metastatic renal cell carcinoma: The results of Southwest Oncology Group (SWOG) trial 8949 [abstract 685]. J Urol. 1999;163(suppl):154.
26. Mickisch GH, Garin A, Madej M, et al. Tumor nephrectomy plus interferon alpha is superior to interferon alpha alone in metastatic renal cell carcinoma [abstract 778]. J Urol. 1999;163(suppl):176.
27. Figlin RA, Renal cell carcinoma: Management of advanced disease. J Urol. 1999;161:381-387.